Clinical Response of Antilymphocyte Globulin-Based Treatment in Patients in Taiwan with Aplastic Anemia: Positive Hepatitis C Antibody May Represent a Response Predictor

International Journal of Hematology

Volumn 79, Issue 2, 2004, Pages 133-137

  Feng, Yin Hsun ^a   Yen, Chia Jui ^a   Huang, Wen Tsung ^a   Su, Wu Chou ^a   Chen, Tsai Yun ^a   Tsao, Chao Jung ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

ALG; Aplastic anemia; Chinese; Hepatitis C

Indexed keywords

ANDROGEN; CYCLOSPORIN; HEPATITIS C ANTIBODY; LYMPHOCYTE ANTIBODY; STEROID;

ADOLESCENT; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBODY TITER; APLASTIC ANEMIA; ARTICLE; BACTEREMIA; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG RESPONSE; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; MALE; MORTALITY; PREDICTION; PROGNOSIS; RISK ASSESSMENT; SCHOOL CHILD; TAIWAN; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 1442334991     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.A10306     Document Type: Article

References (26)

1. Aoki K. Comments on epidemiology [in Japanese]. In: Hibino S. Takafu F, eds. Aplastic Anemia. Tokyo, Japan: Igaku-Shoin; 1979;1.
2. Shima S, Keto Y. Incidence of aplastic anemia among workers in major industries in Japan and suspected causal factors [in Japanese]. In: Aoki K, Hosoda Y, Yanagawa H, eds. Epidemiology of Intractable Diseases in Japan. Nagoya, Japan: Nagoya University School of Medicine; 1986;53.
3. Yin D, Wu Y, Lin Z. Epidemiological and etiological studies on aplastic anemia in the Mudanjiang area [in Chinese]. Chin J Hematol. 1980;1:33.
4. Deng J, Yang CL, Yang TY. Aplastic anemia [in Chinese]. In: Deng J, Yang CL, Yang TY, eds. Clinical Hematology. Shanghai, China: Science and Technology Publishing Co; 1985.
5. Champlin R, Ho W, Gale RP. Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. N Engl J Med. 1983;308:115-118.
6. Paquette RL, Tebyani N, Frane M, et al. Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation. Blood. 1995;85:283-290.
7. Christine C, Cheryl AS, Thomas RS. Antithymocyte immunoglobulin in severe aplastic anemia and bone marrow transplantation. Ann Pharmacother. 1996;30:1164-1174.
8. Esperou H, Devergie A, Lehn P, Lallemand A, Gluckman E. A randomized study comparing cyclosporine A and antithymocyte globulin for treatment of severe aplastic anemia. Nouv Rev Fr Hematol. 1989;31:65-68.
9. Frickhofen N, Kaltwasser JP, Schrezenmeier H, et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med. 1991;324:1297-1304.
10. Rosenfeld SJ, Kimball J, Vining D, Young NS. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood. 1995;85:3058-3065.
11. Bacigalupo A, Broccia G, Corda G, et al. Antilymphocyte globulin, cyclosporine, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia: a pilot study of the EBMT SAA Working Party. Blood. 1995;85:1348-1353.
12. Jin JY, Kim DW, Lee JW, et al. Immune suppression therapy in aplastic anemia: influencing factors on response and survival. Korean J Intern Med. 1995;10:25-31.
13. Ji SQ, Zu M, Wu ZZ. Correlation study of in vitro tests with clinical response to ALG therapy in patients with severe aplastic anemia [in Chinese]. Zhonghua Nei Ke Za Zhi. 1989;28:222-225.
14. Hanada M, Kishimoto Y, Nakai K, et al. Antithymocyte globulin treatment in 11 patients with aplastic anemia [in Japanese]. Rinsho Ketsueki. 2000;41:563-567.
15. Kojima S, Hibi S, Yamamoto M, et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood. 2000;96:2049-2054.
16. Frickhofen N, Rosenfeld S. Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine. Semin Hematol. 2000;37:56-68.
17. Mikhailova EA, Iadrikhinskaia VN, Savchenko VG. Aplastic anemia and viral hepatitis (posthepatitic aplastic anemia) [in Russian]. Ter Arkh. 1999;71:64-69.
18. Tzakis AG, Arditi M, Whitington PF, et al. Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis. N Engl J Med. 1988;319:393-396.
19. Paquette RL, Kuramoto K, Tran L, Sopher G, Nimer SD, Zeldis JB. Hepatitis C virus infection in acquired aplastic anemia. Am J Hematol. 1998;58:122-126.
20. Hibbs JR, Frickhofen N, Rosenfeld SJ, et al. Aplastic anemia and viral hepatitis: nonA, nonB, nonC? JAMA. 1992;267:2051-2054.
21. Manzin A, Candela M, Paolucci S, Caniglia ML, Gabrielli A, Clementi M. Presence of hepatitis C virus genomic RNA and viral replicative intermediate in bone marrow and peripheral blood mononuclear cells from HCV-infected patients. Clin Diagn Lab Immunol. 1994;1:160-163.
22. Krause DS, Fackler MJ, Civin CI, May WS. CD34: structure, biology, and clinical utility. Blood. 1996;87:1-13.
23. Peters M, Trippler M, Lohr H, et al. Posttransfusional LKM-1-autoantibody-positive hepatitis C virus infection, cryoglobulinemia and aplastic anemia. Dig Dis Sci. 1995;40:763-773.
24. Bronowicki JP, Loriot MA, Thiers V, Grignon Y, Zignego AL, Brechot C. Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice. Hepatology. 1998;28:211-218.
25. Bacigalupo A, Chaple M, Hows J, et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without androgens: a randomized trial from the EBMT SAA working party. Br J Haematol. 1993;3:145-151.
26. Gluckman E, Esperou-Bourdeau H, Baruchel A, et al. Multicenter randomized study comparing cyclosporine-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. Blood. 1992;79:2540-2546.